Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor

Tekijä Cawston, Erin E, Miller, Laurence J
Julkaistu 2010

Fluorescence Polarization Screening for Allosteric Small Molecule Ligands of the Cholecystokinin Receptor

Tekijä Harikumar, Kaleeckal G., Cawston, Erin E., Miller, Laurence J.
Julkaistu 2011

Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity

Tekijä Cawston, Erin E., Harikumar, Kaleeckal G., Miller, Laurence J.
Julkaistu 2012

Real-time characterization of cannabinoid receptor 1 (CB(1)) allosteric modulators reveals novel mechanism of action

Tekijä Cawston, Erin E, Redmond, William J, Breen, Courtney M, Grimsey, Natasha L, Connor, Mark, Glass, Michelle
Julkaistu 2013

Identification of N‐arachidonoyl dopamine as a highly biased ligand at cannabinoid CB(1) receptors

Tekijä Redmond, William J., Cawston, Erin E., Grimsey, Natasha L., Stuart, Jordyn, Edington, Amelia R., Glass, Michelle, Connor, Mark
Julkaisussa Br J Pharmacol (2015)

Gα(s) signalling of the CB(1) receptor and the influence of receptor number

Tekijä Finlay, David B, Cawston, Erin E, Grimsey, Natasha L, Hunter, Morag R, Korde, Anisha, Vemuri, V Kiran, Makriyannis, Alexandros, Glass, Michelle
Julkaisussa Br J Pharmacol (2017)

Molecular Basis for Benzodiazepine Agonist Action at the Type 1 Cholecystokinin Receptor

Tekijä Harikumar, Kaleeckal G., Cawston, Erin E., Lam, Polo C. H., Patil, Achyut, Orry, Andrew, Henke, Brad R., Abagyan, Ruben, Christopoulos, Arthur, Sexton, Patrick M., Miller, Laurence J.
Julkaistu 2013

Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor

Tekijä Cawston, Erin E., Lam, Polo C. H., Harikumar, Kaleeckal G., Dong, Maoqing, Ball, Alicja M., Augustine, Mary Lou, Akgün, Eyup, Portoghese, Philip S., Orry, Andrew, Abagyan, Ruben, Sexton, Patrick M., Miller, Laurence J.
Julkaistu 2012